Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parr

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Journal of Autism and Developmental Disorders|November 28, 2017
The Association Between Child and Family Characteristics and the Mental Health and Wellbeing of Caregivers of Children with Autism in Mid-ChildhoodErica Salomone, Kathy Leadbitter, Catherine Aldred, et al.
Molecular Psychiatry|September 30, 2003
Analysis of reelin as a candidate gene for autismE Bonora, K S Beyer, J A Lamb, et al.
Trials|September 23, 2018
Paediatric Autism Communication Therapy-Generalised (PACT-G) against treatment as usual for reducing symptom severity in young children with autism spectrum disorder: study protocol for a randomised controlled trialJonathan Green, Catherine Aldred, Tony Charman, et al.
Clinical Medicine (London, England)|January 17, 2020
Facilitating transition of young people with long-term health conditions from children's to adults' healthcare services - implications of a 5-year research programmeAllan Colver, Tim Rapley, Jeremy R Parr, et al.
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Chemmedchem|November 1, 2008
Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitisRanga Reddy, Evelyne Dietrich, Yanick Lafontaine, et al.
BJGP Open|May 26, 2022
Views about primary care health checks for autistic adults: UK survey findingsDavid Mason, Helen Taylor, Barry Ingham, et al.
ACS Chemical Biology|January 6, 2016
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding ProteinsAndrew M King, Dustin T King, Shawn French, et al.
Journal of Medicinal Chemistry|September 20, 2002
4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activityAlfonso de Dios, Lourdes Prieto, Jose Alfredo Martín, et al.
Lancet (London, England)|October 30, 2016
Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trialAndrew Pickles, Ann Le Couteur, Kathy Leadbitter, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Journal of Autism and Developmental Disorders|November 28, 2017
The Association Between Child and Family Characteristics and the Mental Health and Wellbeing of Caregivers of Children with Autism in Mid-ChildhoodErica Salomone, Kathy Leadbitter, Catherine Aldred, et al.
Molecular Psychiatry|September 30, 2003
Analysis of reelin as a candidate gene for autismE Bonora, K S Beyer, J A Lamb, et al.
Trials|September 23, 2018
Paediatric Autism Communication Therapy-Generalised (PACT-G) against treatment as usual for reducing symptom severity in young children with autism spectrum disorder: study protocol for a randomised controlled trialJonathan Green, Catherine Aldred, Tony Charman, et al.
Clinical Medicine (London, England)|January 17, 2020
Facilitating transition of young people with long-term health conditions from children's to adults' healthcare services - implications of a 5-year research programmeAllan Colver, Tim Rapley, Jeremy R Parr, et al.
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Chemmedchem|November 1, 2008
Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitisRanga Reddy, Evelyne Dietrich, Yanick Lafontaine, et al.
BJGP Open|May 26, 2022
Views about primary care health checks for autistic adults: UK survey findingsDavid Mason, Helen Taylor, Barry Ingham, et al.
ACS Chemical Biology|January 6, 2016
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding ProteinsAndrew M King, Dustin T King, Shawn French, et al.
Journal of Medicinal Chemistry|September 20, 2002
4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activityAlfonso de Dios, Lourdes Prieto, Jose Alfredo Martín, et al.
Lancet (London, England)|October 30, 2016
Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trialAndrew Pickles, Ann Le Couteur, Kathy Leadbitter, et al.
Pageof 32